Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de John Irving Bell
Age : 69
Public asset : 445,661 USD
Linked companies : Immunocore Holdings plc
Summary 
Dr. John I. Bell, MD, is a Chairman-Partnership Board at Oxford Centre for Diabetes Endocrinology & Metabolism, an Advisor at Biospring Management Partners LP, a Chairman at GMEC Management Co. Ltd., a Chairman at Office for Strategic Co-ordination of Health Research, a Chairman at The Oxford Health Alliance and a Non-Executive Director at The Jenner Institute Laboratories.

He is on the Board of Directors at Immunocore Holdings Plc, Genentech, Inc., Genomics England Ltd., Oxford Science Enterprises PLC, Oxford University Hospitals NHS Trust, The Gray Laboratory Cancer Research Trust, Rhodes Trust and The Ewelme Almshouse Charity.

Dr. Bell was previously employed as a President by Academy of Medical Sciences, a Non-Executive Director by Roche Holding AG, a Non-Executive Director by Oxagen Ltd., a Founder by The Wellcome Trust Centre for Human Genetics, a Chairman-Medicine Department & Professor by University of Oxford, an Independent Non-Executive Director by Avidex Ltd., a Non-Executive Director by F. Hoffmann-La Roche Ltd., and a Chairman by Sensyne Health Plc.

He also served on the board at Atopix Therapeutics Ltd. and Powderject Pharmaceuticals Plc.

He received his undergraduate degree from Magdalen College School Oxford Ltd, an undergraduate degree from the University of Alberta and a doctorate degree from Magdalen College School Oxford Ltd.


Current positions of John Irving Bell 
NameTitle Since
Immunocore Holdings plc
(Biotechnology & Medical Research)
Chairman -
The Oxford Health Alliance Chairman -
GMEC Management Co. Ltd. Chairman -
Office for Strategic Co-ordination of Health Research Chairman -
Genentech, Inc. Director 2009
Rhodes Trust Trustee -
Oxford University Hospitals NHS Trust Non-Executive Director -
The Gray Laboratory Cancer Research Trust Non-Executive Director -
The Ewelme Almshouse Charity Trustee -
Genomics England Ltd. Non-Executive Director -
Oxford Science Enterprises PLC Non-Executive Director -
Our Future Health Uk Trustee -
The Jenner Institute Laboratories Non-Executive Director 2013
Oxford Centre for Diabetes Endocrinology & Metabolism Chairman-Partnership Board 1999
Biospring Management Partners LP Advisor -


Holdings of John Irving Bell 
NameEquities%Valuation
Immunocore Holdings Plc13,4520.033%438,670 USD
Sensyne Health plc (SENS)
(Software)
359,2890.22%6,992 USD


John Irving Bell: Personal Network 
Most Read News 
05/11CATHIE WOOD : Tumble in Coinbase pushes Wood's ARK fund closer to pandemic low
RE
05/02ELON MUSK : Musk seeks to put in less money in new Twitter deal financing -sources
RE
05/14ELON MUSK : Elon Musk says Twitter legal team told him he violated an NDA
RE
05/11ELON MUSK : Musk's delay in disclosing Twitter stake triggers SEC probe - WSJ
RE
05/05LARRY ELLISON : Musk to lead Twitter temporarily after $44 billion takeover - source
RE
05/12MASAYOSHI SON : SoftBank Vision Fund posts $26 billion loss; Son pledges defence
RE
05/03Stocks rise, U.S. yields slip as markets await Fed rate hike
RE
05/04WARREN BUFFETT : Berkshire shareholders overwhelmingly vote to keep Buffett chairman
RE
05/03ELON MUSK : Elon Musk plans to take Twitter public again later - WSJ
RE
05/05JACK DORSEY : Dorsey-led Block beats operating profit estimates, shares surge 10%
RE
More news


© 2022 People and Ownership :   
John Irving Bell : Connections